Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SynAct Pharma | 1,516,870 | net | 01 Jun 2023 | tx 9+1,516,870 |
| GLCapital AB | 30,302 | net | 22 May 2018 | tx 1+30,302 |
| Synact Pharma AB | 9,343 | net | 06 Jul 2016 | tx 1+9,343 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2023 | GRANT_AWARD | SynAct Pharma | 200,000 | 0.00 SEK | deriv |
| 16 Jan 2023 | PURCHASE | SynAct Pharma | 15,355 | 62.60 SEK | |
| 02 May 2022 | PURCHASE | SynAct Pharma | 1,985 | 63.00 SEK | first after silence |
| 22 Jul 2020 | OTHER | SynAct Pharma | 29,840 | 6.70 SEK | |
| 22 Jul 2020 | OTHER | SynAct Pharma | 29,840 | 0.00 SEK | deriv |
| 12 Dec 2019 | OTHER | SynAct Pharma | 606,852 | 0.00 SEK | |
| 03 Dec 2019 | PURCHASE | SynAct Pharma | 7,460 | 24.80 SEK | first after silence |
| 22 May 2018 | PURCHASE | GLCapital AB | 30,302 | 9.90 SEK | first after silence |
| 22 Mar 2017 | OTHER | SynAct Pharma | 18,686 | 6.40 SEK | |
| 06 Jul 2016 | PURCHASE | Synact Pharma AB | 9,343 | 32.00 SEK |
3 purchases reported after at least 12 months of silence — most recent on 02 May 2022.